FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

771590007: Erenumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3706918013 Erenumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3706919017 Erenumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1131221000172116 érénumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)
1244101000172117 erenumab nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erenumab Is a Monoclonal antibody true Inferred relationship Some
Erenumab Has disposition (attribute) Calcitonin gene-related peptide receptor antagonist (disposition) true Inferred relationship Some
Erenumab Is a Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Erenumab-containing product Has active ingredient True Erenumab Inferred relationship Some 1
Erenumab-containing product in parenteral dose form Has active ingredient True Erenumab Inferred relationship Some 1
Product containing only erenumab (medicinal product) Has active ingredient True Erenumab Inferred relationship Some 1
Erenumab only product in parenteral dose form Has active ingredient True Erenumab Inferred relationship Some 1
Erenumab 70 mg/mL solution for injection Has precise active ingredient True Erenumab Inferred relationship Some 1
Erenumab 70 mg/mL solution for injection Has basis of strength substance (attribute) True Erenumab Inferred relationship Some 1
Product containing precisely erenumab 140 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Erenumab Inferred relationship Some 1
Product containing precisely erenumab 140 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Erenumab Inferred relationship Some 1

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug

Back to Start